Nanoform Finland Plc
Save
105.37M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Similar securities
Based on sector and market capitalization
Report issue